Matches in SemOpenAlex for { <https://semopenalex.org/work/W4324344607> ?p ?o ?g. }
- W4324344607 endingPage "53" @default.
- W4324344607 startingPage "41" @default.
- W4324344607 abstract "Epidermal growth factor receptor (EGFR) mutation is the most common driver mutation in non-small cell lung cancer (NSCLC). The first-line therapy for advanced NSCLC patients with EGFR-sensitive mutation is the EGFR tyrosine kinase inhibitor (EGFR-TKI). However, most NSCLC patients with EGFR mutation will develop resistant mutations in EGFR-TKI therapy. With further studies, resistance mechanisms represented by EGFR-T790M mutations have revealed the impact of EGFR mutations in situ on EGFR-TKIs sensitivity. The third-generation EGFR-TKIs inhibit both EGFR-sensitive mutations and T790M mutations. The emergence of novel mutations such as EGFR-C797S and EGFR-L718Q may decrease efficacy. Searching for new targets to overcome EGFR-TKI resistance becomes a key challenge. Therefore, an in-depth understanding of the regulatory mechanisms of EGFR is essential to find novel targets to overcome drug-resistant mutations in EGFR-TKIs. EGFR, as a receptor-type tyrosine kinase, undergoes homo/heterodimerization and autophosphorylation upon binding to ligands, which activates multiple downstream signaling pathways. Interestingly, there is growing evidence that the kinase activity of EGFR is affected not only by phosphorylation but also by various post-translational modifications (PTMs, such as S-palmitoylation, S-nitrosylation, Methylation, etc.). In this review, we systematically review the effects of different protein PTMs on EGFR kinase activity and its functionality and suggest that influencing EGFR kinase activity by modulating multiple EGFR sites are potential targets to overcome EGFR-TKIs resistance mutations." @default.
- W4324344607 created "2023-03-16" @default.
- W4324344607 creator A5012182133 @default.
- W4324344607 creator A5012788597 @default.
- W4324344607 creator A5021669964 @default.
- W4324344607 creator A5023541354 @default.
- W4324344607 creator A5037828672 @default.
- W4324344607 creator A5060314863 @default.
- W4324344607 creator A5062121622 @default.
- W4324344607 creator A5062500348 @default.
- W4324344607 creator A5079477151 @default.
- W4324344607 creator A5081701436 @default.
- W4324344607 date "2023-04-01" @default.
- W4324344607 modified "2023-10-15" @default.
- W4324344607 title "Multiple post-translational modifications ensure EGFR functionality: Potential therapeutic targets to overcome its drug-resistance mutations" @default.
- W4324344607 cites W1069638384 @default.
- W4324344607 cites W1536336415 @default.
- W4324344607 cites W1544833181 @default.
- W4324344607 cites W1546552389 @default.
- W4324344607 cites W1772468519 @default.
- W4324344607 cites W1936571436 @default.
- W4324344607 cites W1950601528 @default.
- W4324344607 cites W1964928061 @default.
- W4324344607 cites W1966658428 @default.
- W4324344607 cites W1967391569 @default.
- W4324344607 cites W1972960760 @default.
- W4324344607 cites W1984871500 @default.
- W4324344607 cites W1991691364 @default.
- W4324344607 cites W1994499102 @default.
- W4324344607 cites W1996218285 @default.
- W4324344607 cites W2010225513 @default.
- W4324344607 cites W2010897402 @default.
- W4324344607 cites W2012322739 @default.
- W4324344607 cites W2012944100 @default.
- W4324344607 cites W2015141062 @default.
- W4324344607 cites W2022847745 @default.
- W4324344607 cites W2026539434 @default.
- W4324344607 cites W2028349074 @default.
- W4324344607 cites W2029935304 @default.
- W4324344607 cites W2033395428 @default.
- W4324344607 cites W2040299716 @default.
- W4324344607 cites W2042345580 @default.
- W4324344607 cites W2042386784 @default.
- W4324344607 cites W2042553386 @default.
- W4324344607 cites W2044512608 @default.
- W4324344607 cites W2045755077 @default.
- W4324344607 cites W2047192016 @default.
- W4324344607 cites W2048193567 @default.
- W4324344607 cites W2051201358 @default.
- W4324344607 cites W2057175119 @default.
- W4324344607 cites W2059715478 @default.
- W4324344607 cites W2070448053 @default.
- W4324344607 cites W2070727232 @default.
- W4324344607 cites W2073066468 @default.
- W4324344607 cites W2084796079 @default.
- W4324344607 cites W2088540000 @default.
- W4324344607 cites W2094630580 @default.
- W4324344607 cites W2099203391 @default.
- W4324344607 cites W2099420302 @default.
- W4324344607 cites W2100794900 @default.
- W4324344607 cites W2130213960 @default.
- W4324344607 cites W2132448632 @default.
- W4324344607 cites W2136343696 @default.
- W4324344607 cites W2137480570 @default.
- W4324344607 cites W2144436378 @default.
- W4324344607 cites W2151016309 @default.
- W4324344607 cites W2153188090 @default.
- W4324344607 cites W2154870995 @default.
- W4324344607 cites W2154969724 @default.
- W4324344607 cites W2159013299 @default.
- W4324344607 cites W2161821474 @default.
- W4324344607 cites W2165942284 @default.
- W4324344607 cites W2168691181 @default.
- W4324344607 cites W2169460814 @default.
- W4324344607 cites W2170824881 @default.
- W4324344607 cites W2176390318 @default.
- W4324344607 cites W2177833054 @default.
- W4324344607 cites W2199673223 @default.
- W4324344607 cites W2302518824 @default.
- W4324344607 cites W2346299551 @default.
- W4324344607 cites W2400274474 @default.
- W4324344607 cites W2409105645 @default.
- W4324344607 cites W2466976250 @default.
- W4324344607 cites W2490543344 @default.
- W4324344607 cites W2554688226 @default.
- W4324344607 cites W2555875659 @default.
- W4324344607 cites W2561418597 @default.
- W4324344607 cites W2565077351 @default.
- W4324344607 cites W2567682222 @default.
- W4324344607 cites W2595645511 @default.
- W4324344607 cites W2596425928 @default.
- W4324344607 cites W2613008121 @default.
- W4324344607 cites W2615601352 @default.
- W4324344607 cites W2647580717 @default.
- W4324344607 cites W2729725748 @default.
- W4324344607 cites W2753756015 @default.
- W4324344607 cites W2760639821 @default.
- W4324344607 cites W2762724643 @default.